These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 20529558

  • 1. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
    Zhao LJ, Liu N, Li XP, Wang JL, Wei LH.
    Chin Med J (Engl); 2010 May 05; 123(9):1170-5. PubMed ID: 20529558
    [Abstract] [Full Text] [Related]

  • 2. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ, Wei LH, Li XP, Wang JL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan 05; 44(1):45-9. PubMed ID: 19563062
    [Abstract] [Full Text] [Related]

  • 3. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S, Schlotawa L, Günthert AR, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jan 05; 24(1):24-9. PubMed ID: 17943530
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM, Cheng JC, Wang HS, Huang HY, MacCalman CD, Leung PC.
    Cancer Res; 2009 May 15; 69(10):4202-8. PubMed ID: 19366794
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S, Günthert AR, Emons G, Gründker C.
    Cancer Res; 2007 Feb 15; 67(4):1750-6. PubMed ID: 17308117
    [Abstract] [Full Text] [Related]

  • 6. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog.
    Kim JW, Lee YS, Kim BK, Park DC, Lee JM, Kim IK, Namkoong SE.
    Gynecol Oncol; 1999 Jun 15; 73(3):368-71. PubMed ID: 10366462
    [Abstract] [Full Text] [Related]

  • 7. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct 15; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 8. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM, Wei LH, Gao M, Wang JL, Zhao LJ, Wang DP, Zhang JX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun 15; 42(6):408-11. PubMed ID: 17697604
    [Abstract] [Full Text] [Related]

  • 9. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C.
    Cancer Res; 2009 Aug 15; 69(16):6473-81. PubMed ID: 19638591
    [Abstract] [Full Text] [Related]

  • 10. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
    Eicke N, Günthert AR, Emons G, Gründker C.
    Int J Oncol; 2006 Nov 15; 29(5):1223-9. PubMed ID: 17016655
    [Abstract] [Full Text] [Related]

  • 11. [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells].
    Bao XX, Wang JL, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar 15; 47(3):212-7. PubMed ID: 22781074
    [Abstract] [Full Text] [Related]

  • 12. Stromal cell-derived factor 1alpha stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt.
    Zhao D, Li XP, Gao M, Zhao C, Wang JL, Wei LH.
    Gynecol Oncol; 2006 Dec 15; 103(3):932-7. PubMed ID: 16884765
    [Abstract] [Full Text] [Related]

  • 13. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
    Borri P, Coronnello M, Noci I, Pesciullesi A, Peri A, Caligiani R, Maggi M, Torricelli F, Scarselli G, Chieffi O, Mazzei T, Mini E.
    Gynecol Oncol; 1998 Dec 15; 71(3):396-403. PubMed ID: 9887238
    [Abstract] [Full Text] [Related]

  • 14. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L, Yang YB, Shen HM, Xu CF, Wang XY, Li XM.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep 15; 44(9):681-5. PubMed ID: 20079181
    [Abstract] [Full Text] [Related]

  • 15. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G, Schröder B, Ortmann O, Westphalen S, Schulz KD, Schally AV.
    J Clin Endocrinol Metab; 1993 Dec 15; 77(6):1458-64. PubMed ID: 8263128
    [Abstract] [Full Text] [Related]

  • 16. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L, Yano T, Osuga Y, Nakagawa S, Oishi H, Wada-Hiraike O, Tang X, Yano N, Kugu K, Schally AV, Taketani Y.
    Int J Oncol; 2008 Mar 15; 32(3):593-601. PubMed ID: 18292936
    [Abstract] [Full Text] [Related]

  • 17. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N, Oshita T, Mukai K, Shiroyama Y, Shigemasa K, Ohama K.
    Int J Mol Med; 2002 Nov 15; 10(5):593-7. PubMed ID: 12373298
    [Abstract] [Full Text] [Related]

  • 18. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G, Li X, Zhang L, Zhao L, Jiang J, Wang J, Wei L.
    Cancer Genet Cytogenet; 2010 Jul 15; 200(2):140-8. PubMed ID: 20620597
    [Abstract] [Full Text] [Related]

  • 19. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB, Honig A, Schönhals T, Weidler C, Häusler S, Krockenberger M, Grunewald TG, Dombrowski Y, Rieger L, Dietl J, Wischhusen J.
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov 15; 141(1):64-9. PubMed ID: 18687514
    [Abstract] [Full Text] [Related]

  • 20. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
    Engel JB, Keller G, Schally AV, Nagy A, Chism DD, Halmos G.
    Fertil Steril; 2005 Apr 15; 83 Suppl 1():1125-33. PubMed ID: 15831285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.